Immunological aspects of controlled antigen delivery

被引:57
作者
Lofthouse, S [1 ]
机构
[1] Univ Melbourne, Sch Vet Sci, Ctr Anim Biotechnol, Melbourne, Vic 3010, Australia
关键词
vaccine delivery; antigen delivery; single shot; vaccination; immune response;
D O I
10.1016/S0169-409X(02)00073-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent advances in controlled delivery systems for protein pharmaceuticals such as microspheres, liposomes, pumps and implants, have provided a new avenue for delivery of vaccine antigens. There has, however, been considerable confusion over the way in which continuous antigen delivery affects the outcome of an immune response. To date, there has been little systematic study of the influence of varying antigen exposure times and release profiles on the phenotype of the immune response, or indeed the balance between immunity and tolerance as most studies have concentrated on optimising responses to a particular antigen of interest in a single model system. As these delivery systems would find particular advantages in management of livestock species, where the use of a single administration vaccine would significantly enhance management practices, it is important to understand the relationship between controlled antigen delivery and immunity. This paper describes how existing controlled antigen delivery studies have contributed to our understanding of the development of the immune response and demonstrates how continuous antigen delivery is useful, and possibly advantageous in the generation of immunity, the maturation of the immune response and the extension of the effector response. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:863 / 870
页数:8
相关论文
共 56 条
[1]  
ABD EM, 2000, J DRUG TARGET, V7, P355
[2]  
Afrin F, 2000, J PARASITOL, V86, P730, DOI 10.1645/0022-3395(2000)086[0730:IOPPAL]2.0.CO
[3]  
2
[4]   A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice [J].
Babai, I ;
Samira, S ;
Barenholz, Y ;
Zakay-Rones, Z ;
Kedar, E .
VACCINE, 1999, 17 (9-10) :1239-1250
[5]   Oral vaccination with alginate microsphere systems [J].
Bowersock, TL ;
HogenEsch, H ;
Suckow, M ;
Porter, RE ;
Jackson, R ;
Park, H ;
Park, K .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :209-220
[6]   Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres [J].
Bowersock, TL ;
HogenEsch, H ;
Torregrosa, S ;
Borie, D ;
Wang, B ;
Park, H ;
Park, K .
IMMUNOLOGY LETTERS, 1998, 60 (01) :37-43
[7]   Vaccine delivery to animals [J].
Bowersock, TL ;
Martin, S .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 38 (02) :167-194
[8]   Vaccines for fertility regulation of wild and domestic species [J].
Bradley, MP ;
Eade, J ;
Penhale, J ;
Bird, P .
JOURNAL OF BIOTECHNOLOGY, 1999, 73 (2-3) :91-101
[9]   Extended release peptide delivery systems through the use of PLGA microsphere combinations [J].
Burton, KW ;
Shameem, M ;
Thanoo, BC ;
DeLuca, PP .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2000, 11 (07) :715-729
[10]   In vitro testing of a pulsatile delivery system and its in vivo application for immunisation against tetanus toxoid [J].
Cardamone, M ;
Lofthouse, SA ;
Lucas, JC ;
Lee, RP ;
ODonoghue, M ;
Brandon, MR .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (03) :205-219